BETHLEHEM, Pa.--(BUSINESS WIRE)--OraSure Technologies, Inc. (NASDAQ:OSUR) today announced the results of its arbitration with Prestige Brands Holdings, Inc (NYSE:PBH). Since April 2003, Prestige has exclusively distributed OraSure’s cryosurgical wart removal product in the United States over-the-counter or retail (“OTC”) market under the Compound W Freeze Off® tradename. The arbitration arose after Prestige acquired the Wartner® cryosurgical wart removal product line in September 2006. Wartner® competes directly in the domestic OTC market against the Freeze Off™ product, in violation of a non-compete provision contained in the parties’ distribution agreement.
